Sung Hoon Noh

Research interests

Publications

• PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

  Journal of Clinical Oncology · 2021 · https://doi.org/10.1200/jco.20.02914

• Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.01124

• A Lesion-Based Convolutional Neural Network Improves Endoscopic Detection and Depth Prediction of Early Gastric Cancer

  Journal of Clinical Medicine · 2019 · https://doi.org/10.3390/jcm8091310

• Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype

  Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-04179-8

• Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis

  The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30108-6

• Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer

  Annals of Surgery · 2018 · https://doi.org/10.1097/sla.0000000000002803

• Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project

  Clinical Cancer Research · 2017 · https://doi.org/10.1158/1078-0432.ccr-16-2211

• Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project

  Clinical Cancer Research · 2017 · https://doi.org/10.1158/1078-0432.ccr-16-2211

• Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70473-5

• Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas

  Gut · 2014 · https://doi.org/10.1136/gutjnl-2014-308252

• Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

  The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(11)61873-4

• Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer

  Clinical Cancer Research · 2011 · https://doi.org/10.1158/1078-0432.ccr-10-2180

• Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy

  Gastroenterology · 2011 · https://doi.org/10.1053/j.gastro.2011.04.042

• Role of robotic gastrectomy using da Vinci system compared with laparoscopic gastrectomy: initial experience of 20 consecutive cases

  Surgical Endoscopy · 2009 · https://doi.org/10.1007/s00464-009-0351-4

• Robot-Assisted Gastrectomy With Lymph Node Dissection for Gastric Cancer

  Annals of Surgery · 2009 · https://doi.org/10.1097/01.sla.0000351688.64999.73

• Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

  Annals of Oncology · 2008 · https://doi.org/10.1093/annonc/mdn026

• CT and PET in Stomach Cancer: Preoperative Staging and Monitoring of Response to Therapy

  Radiographics · 2006 · https://doi.org/10.1148/rg.261055078

• Early gastric carcinoma with signet ring cell histology

  Cancer · 2001 · https://doi.org/10.1002/cncr.10120

• Recurrence following curative resection for gastric carcinoma

  British journal of surgery · 2000 · https://doi.org/10.1046/j.1365-2168.2000.01360.x

Current projects

No projects listed.